Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-25-018480
Filing Date
2025-01-31
Accepted
2025-01-31 17:21:10
Documents
14
Effectiveness Date
2025-01-31

Document Format Files

Seq Description Document Type Size
1 S-3ASR d894895ds3asr.htm S-3ASR 413809
2 EX-1.2 d894895dex12.htm EX-1.2 246422
3 EX-4.4 d894895dex44.htm EX-4.4 97386
4 EX-4.5 d894895dex45.htm EX-4.5 97721
5 EX-4.7 d894895dex47.htm EX-4.7 84734
6 EX-4.8 d894895dex48.htm EX-4.8 303667
7 EX-5.1 d894895dex51.htm EX-5.1 27926
8 EX-23.1 d894895dex231.htm EX-23.1 1718
9 EX-FILING FEES d894895dexfilingfees.htm EX-FILING FEES 48866
10 GRAPHIC g894895g0131045851144.jpg GRAPHIC 2537
11 GRAPHIC g894895g09r61.jpg GRAPHIC 29766
12 GRAPHIC g894895g28p57.jpg GRAPHIC 29988
13 GRAPHIC g894895g39b59.jpg GRAPHIC 36375
14 GRAPHIC g894895g61h60.jpg GRAPHIC 36497
  Complete submission text file 0001193125-25-018480.txt   1510344
Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Filer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-284650 | Film No.: 25579502
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)